Company News Archive

Natural based medicinal chemistry

Medicinal Chemistry & Synthesis: Bicoll seamlessly guides your synthesis and lead optimization projects through drug discovery and development with intensive understanding of structure-activity relationships, capability in biological data
interpretation, solid knowledge of intellectual property and patent aspects. Reliable and fast reporting under your specific requirements. Hit generation speeds up your access to unique sets of compounds …

Plant-based natural products: Most successful source of top 200 pharmaceutical products

Product development candidates into your drug discovery projects: Intelligent screening with Bicoll Profiles™ – innovative techniques, methods and equipment accompanied with the extensive experience and expertise of our scientists in natural product chemistry. Bicoll Plant Profiles™ give you access to the most promising source of new patentable, high quality leads in 9 months at a …

12th Wartburg Symposium on Flavor Chemistry & Biology

Eisenach, Germany, May 21 – 24, 2019 Cutting-edge research in taste and smell returns once more to the beautiful “Hotel on the Wartburg” in Eisenach, Germany. Since its inception in 1978, the Wartburg Symposium on Flavor Chemistry & Biology has convened every three years. It is today firmly established as an internationally leading, top-tier forum …

Business Conference in Ibaraki, Japan

Tsukuba, Ibaraki – Bicoll presents at Ibaraki Business conference, February 19-20, 2019 On February 19 (Tue.) and 20 (Wed.), 2019, the Ministry of Economy, Trade and Industry (METI), the Japan External Trade Organization (JETRO) and Ibaraki Prefecture will jointly hold a conference titled “Regional Business Conference (RBC) in Ibaraki”. The organizers will invite overseas companies …

RINK Festival 2019, Kawasaki, Japan

Kawasaki, Kanagawa, February 8 2019 – Bicoll joins RINK Festival 2019 with video presentation. RINK is a network that has been established for the purpose of creating innovation by companies located in the Life Innovation Center (LIC), a center located in Tonomachi near Haneda Airport that is a base for the industrialization of regenerative medicine …

EpimiRNA FP7 Grant: working to improve lives of patients

Bicoll brings in its medicinal chemistry competence as an active participant of EpimiRNA project. A first novel lead structure preventing seizures in a human tissue model could be provided through the consortium efforts. Furthermore, there are a number of results achieved already such as identification of new microRNAs, that control brain excitability etc. There are …

China Biotech revolution, special edition

China Biotech revolution, special edition: “Bicoll is the first German-Chinese biotech company.” (Dr. Kai Lamottke, Bicoll GmbH, CEO). Those who missed the printed version – order the e-paper in German or Chinese PDF Download (German)

EpimiRNA: 5 years of successful work to reduce the seizures

5 years of collaborative work with 16 partners under the 7th Framework Programme have been finished with the great results and desire to work further on epilepsy. Bicoll small molecule appeared to be reducing the epileptic seizures and miRNA can block epilepsy. A number of other achievements have been done during these 5 years (e.g. …

BioJapan 2018 and Osaka, ジャパン

医薬、医療から研究機器、設備、エネルギーまで!バイオ産業の「今」が集結!  On the 9th of October Bicoll participates in 欧州のライフサイエンス企業との商談会 in Osaka 2018 European Biotech and Pharma Partnering Conference, Osaka 2018 From 10th till 12th of October Bicoll will exhibit under the umbrella of GermanPavilion (Partnering meetings are also available)  @ BioJapan2018 in Yokohama バイオビジネスにおけるアジア最大級のパートナリングイベント

Important
This Site uses cookies, which could include third-party cookies, to ensure its technical functioning and which may contain tracking information about visitors. By continuing to browse this site you agree to our use of cookies. If you want to learn more about our Privacy Policy click here.